International audienceIntroductionIn France, vaccination against human papilloma virus (HPV) was recommended in 2007 for all 14-year-old girls as well as “catch-up” vaccination for girls between 15-23 years of age either before or within one year of becoming sexually active. We evaluated the vaccine coverage according to the eligibility for vaccination in a sample of young girls aged 14 to 23 years, who were seen in general practices. Patients and methodsA survey was proposed to 706 general practitioners (GPs) and carried out from July to September 2010. GPs, also called “family doctor”, are physicians whose practice is not restricted to a specific field of medicine but instead covers a variety of medical problems in patients of all ages. E...
INTRODUCTION: The uptake of human papillomavirus (HPV) vaccination in France remains low. The aim of...
Seventy percent of sexually active individuals will be infected with Human Papillomavirus (HPV) duri...
La vaccination anti-HPV, recommandée en France depuis mars 2007 chez les jeunes filles de 14 ans et ...
International audienceIntroductionIn France, vaccination against human papilloma virus (HPV) was rec...
International audienceSummaryIntroduction Human papillomavirus (HPV) is the main cause of cervical c...
SummaryIntroductionHuman papillomavirus (HPV) is the main cause of cervical cancer. In France, since...
Introduction – In France, HPV vaccination is recommended for girls up to 19 years old and for men wh...
International audienceOBJECTIVES:To use both quantitative and qualitative methods to investigate the...
International audienceBackground: The French Cancer Plan 2014-2019 had a target of 60% HPV vaccine c...
GoalsPersistent infection with the human papillomavirus, also known by the acro-nym HPV, a sexually ...
Outcome. HPV vaccination has been recommended in France since 2006. Nevertheless, vaccination covera...
AbstractBackgroundIn France, the human papillomavirus vaccine is routinely recommended for 14-year-o...
International audienceBackground: It has been proven that vaccination is effective against Human Pap...
INTRODUCTION: The uptake of human papillomavirus (HPV) vaccination in France remains low. The aim of...
Seventy percent of sexually active individuals will be infected with Human Papillomavirus (HPV) duri...
La vaccination anti-HPV, recommandée en France depuis mars 2007 chez les jeunes filles de 14 ans et ...
International audienceIntroductionIn France, vaccination against human papilloma virus (HPV) was rec...
International audienceSummaryIntroduction Human papillomavirus (HPV) is the main cause of cervical c...
SummaryIntroductionHuman papillomavirus (HPV) is the main cause of cervical cancer. In France, since...
Introduction – In France, HPV vaccination is recommended for girls up to 19 years old and for men wh...
International audienceOBJECTIVES:To use both quantitative and qualitative methods to investigate the...
International audienceBackground: The French Cancer Plan 2014-2019 had a target of 60% HPV vaccine c...
GoalsPersistent infection with the human papillomavirus, also known by the acro-nym HPV, a sexually ...
Outcome. HPV vaccination has been recommended in France since 2006. Nevertheless, vaccination covera...
AbstractBackgroundIn France, the human papillomavirus vaccine is routinely recommended for 14-year-o...
International audienceBackground: It has been proven that vaccination is effective against Human Pap...
INTRODUCTION: The uptake of human papillomavirus (HPV) vaccination in France remains low. The aim of...
Seventy percent of sexually active individuals will be infected with Human Papillomavirus (HPV) duri...
La vaccination anti-HPV, recommandée en France depuis mars 2007 chez les jeunes filles de 14 ans et ...